Mylan’s Generic Version of Biogen’s MS Drug Gets FDA Approval Post author:Sam Post published:August 20, 2020 Post category:Devices & Diagnostics Letter Mylan has launched the product in 120mg and 240mg delayed-release capsule forms. Source: Devices & Diagnostics Letter You Might Also Like Akili Grabs CE Mark for Children’s Digital ADHD Treatment June 22, 2020 FDA Warns Danish Drugmaker for Testing Failures March 24, 2020 Three More States Pursue Drug Price Controls February 21, 2020